ICAM1 and marginal zone lymphoma: In this study, we found that in BM involvement cases, 62.93% of MCL, 55.56% of MZL, 33.33% HG B-NHL, 14.29% of FL, and 10% of CLL/SLL aberrantly expressed CD54.